API Holdings Ltd (PharmEasy)
Digital pharmacy and pharma distribution group working through a heavy deleveraging cycle.
Market cap
₹6,201 Cr
792.00 Cr shares
P/E ratio
Loss making
Sector average 40
Book value
₹2.94
P/B 2.66
1-year return
-7.56%
52w ₹7 – ₹14
Currently 6% of the way through its 52-week range.
Indicative price history
1Y change
-7.56% ₹8 → ₹8
52-week band in this window: ₹7.83 – ₹13.43. Weekly indicative marks, not exchange-traded prices.
Key highlights
- Largest online pharmacy platform in India by orders, plus a top-three pharma distributor.
- Debt cut by more than half in two years through asset sales and a rights issue.
- Operating cash flow turned positive in FY26.
About PharmEasy
API Holdings is the parent of a digital pharmacy platform, a pharma wholesale distribution business and a diagnostics chain.
The consumer platform sells prescription and over-the-counter medicines with home delivery, while the distribution arm supplies retail chemists.
After an aggressive acquisition phase the group has been selling non-core assets and using proceeds to repay debt.
Where the revenue comes from
- Pharma distribution58%
Wholesale supply to retail chemists
- Consumer platform27%
Online pharmacy orders
- Diagnostics11%
Pathology labs and collection centres
- Other services4%
Teleconsultation and software
Products & services
PharmEasy
Consumer e-pharmacy and teleconsultation app.
Retailio
B2B marketplace for retail chemists.
Thyrocare (stake)
Diagnostics chain, listed subsidiary.
Docon
Clinic management software.
What works
- • Scale in pharma distribution gives purchasing leverage with manufacturers.
- • Repeat purchase behaviour in chronic medication supports predictable order flow.
- • Deleveraging has cut interest cost meaningfully from the peak.
What to watch
- • The group has a history of large losses and goodwill write-downs from past acquisitions.
- • Regulatory uncertainty around online sale of prescription medicines persists.
- • A down round in the past has left many earlier investors holding losses.
Compare with peers
| Company | Price | Market cap | P/E | P/B | Rev CAGR |
|---|---|---|---|---|---|
| PharmEasyThis page | ₹7.83 | ₹6,201 Cr | — | 2.66 | -0.39% |
| OYO | ₹23.40 | ₹21,185 Cr | 21.27 | 6.94 | +31.78% |
| ESDS | ₹405.00 | ₹4,617 Cr | 51.86 | 8.40 | +24.34% |
Latest reported year: FY26 ending 31 Mar 2026.